The effect of hormonal oral contraception on acquisition of peak bone mineral density of adolescents and young women

Journal of Pharmacy Practice

Volumn 25, Issue 3, 2012, Pages 331-340

  Ziglar, Susan ^a   Hunter, Tracy S ^a  

^a WINGATE UNIVERSITY   (United States)

Author keywords

adolescents; bone mineral density; hormonal contraceptives; oral contraceptives

Indexed keywords

CALCIUM; ESTRADIOL; ESTROGEN; ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS LEVONORGESTREL; LO SEASONIQUE; UNCLASSIFIED DRUG;

ADOLESCENT HEALTH; BONE DENSITY; BONE MASS; BONE MINERALIZATION; DIET; EATING DISORDER; EXERCISE; HORMONAL CONTRACEPTION; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MENARCHE; ORAL CONTRACEPTION; PREGNANCY; REVIEW; RISK FACTOR; SMOKING;

EID: 84866289820     PISSN: 08971900     EISSN: 15311937     Source Type: Journal    
DOI: 10.1177/0897190012442066     Document Type: Review

References (45)

1. Abma JC, Martinez GM, Mosher WD, et al. Teenagers in the United States: sexual activity, contraceptive use, and childbearing, 2002. Vital Health Stat. 2004 ; (24). 1-48
2. O'Brien SH, Kaizar EE, Gold MA, et al. Trends in prescribing patterns of hormonal contraceptives for adolescents. Contraception. 2008 ; 77 (4). 264-269
3. Briggs M, Briggs M. Plasma hormone concentrations in women receiving steroid contraceptives. J Obstet Gynaecol Br Commonw. 1972 ; 79 (10). 946-950
4. Murphy PA, Kern SE, Stanczyk FZ, et al. Interaction of St. John's Wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity and breakthrough bleeding. Contraception. 2005 ; 71 (6). 402-408 (Pubitemid 40725774)
5. van den Heuvel MW, van Bragt AJ, Alnabawy AK, et al. Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive. Contraception. 2005 ; 72 (3). 168-174 (Pubitemid 41133355)
6. Sabatier JP, Guaydier-Souquieres G, Benmalek A, et al. Evolution of lumbar bone mineral content during adolescence and adulthood: a longitudinal study in 395 healthy females 10-24 years of age and 206 premenopausal women. Osteoporos Int. 1999 ; 9 (6). 476-482 (Pubitemid 29348561)
7. Boot AM, de Ridder MA, Pols HA, et al. Bone mineral density in children and adolescents: relation to puberty, calcium intake, and physical activity. J Clin Endocrinol Metab. 1997 ; 82 (1). 57-62 (Pubitemid 27021530)
8. Compston JE. Sex steroids and bone. Physiol Rev. 2001 ; 81 (1). 419-447 (Pubitemid 32096180)
9. del Rio L, Carrascosa A, Pons F, et al. Bone mineral density of the lumbar spine in white Mediterranean Spanish children and adolescents: changes related to age, sex, and puberty. Pediatr Res. 1994 ; 35 (3). 362-366 (Pubitemid 24064613)
10. Recker RR, Davies KM, Hinders SM, et al. Bone gain in young adult women. JAMA. 1992 ; 268 (17). 2403-2408
11. Theintz G, Buchs B, Rizzoli R, et al. Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects. J Clin Endocrinol Metab. 1992 ; 75 (4). 1060-1065
12. Kalkwarf HJ, Specker BL. Bone mineral changes during pregnancy and lactation. Endocrine. 2002 ; 17 (1). 49-53 (Pubitemid 34311424)
13. Harel Z, Gold M, Cromer B, et al. Bone mineral density in postmenarchal adolescent girls in the United States: associated biopsychosocial variables and bone turnover markers. J Adolesc Health. 2007 ; 40 (1). 44-53 (Pubitemid 44918376)
14. Polatti F, Perotti F, Filippa N, et al. Bone mass and long-term monophasic oral contraceptive treatment in young women. Contraception. 1995 ; 51 (4). 221-224
15. Cromer BA, Stager M, Bonny A, et al. Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls. J Adolesc Health. 2004 ; 35 (6). 434-441 (Pubitemid 39576013)
16. Cromer BA, Bonny AE, Stager M, et al. Bone mineral density in adolescent females using injectable or oral contraceptives: a 24-month prospective study. Fertil Steril. 2008 ; 90 (6). 2060-2067
17. Pikkarainen E, Lehtonen-Veromaa M, Mottonen T, et al. Estrogen-progestin contraceptive use during adolescence prevents bone mass acquisition: a 4-year follow-up study. Contraception. 2008 ; 78 (3). 226-231
18. Hartard M, Kleinmond C, Wiseman M, et al. Detrimental effect of oral contraceptives on parameters of bone mass and geometry in a cohort of 248 young women. Bone. 2007 ; 40 (2). 444-450 (Pubitemid 46075201)
19. Hartard M, Kleinmond C, Kirchbichler A, et al. Age at first oral contraceptive use as a major determinant of vertebral bone mass in female endurance athletes. Bone. 2004 ; 35 (4). 836-841 (Pubitemid 39349214)
20. Scholes D, Ichikawa L, LaCroix AZ, et al. Oral contraceptive use and bone density in adolescent and young adult women. Contraception. 2010 ; 81 (1). 35-40
21. Almstedt Shoepe H, Snow CM. Oral contraceptive use in young women is associated with lower bone mineral density than that of controls. Osteoporos Int. 2005 ; 16 (12). 1538-1544 (Pubitemid 41790857)
22. Berenson AB, Radecki CM, Grady JJ, et al. A prospective, controlled study of the effects of hormonal contraception on bone mineral density. Obstet Gynecol. 2001 ; 98 (4). 576-582 (Pubitemid 32907449)
23. Lattakova M, Borovsky M, Payer J, et al. Oral contraception usage in relation to bone mineral density and bone turnover in adolescent girls. Eur J Contracept Reprod Health Care. 2009 ; 14 (3). 207-214
24. Lloyd T, Taylor DS, Lin HM, et al. Oral contraceptive use by teenage women does not affect peak bone mass: a longitudinal study. Fertil Steril. 2000 ; 74 (4). 734-738
25. Berenson AB, Rahman M, Breitkopf CR, et al. Effects of depot medroxyprogesterone acetate and 20-microgram oral contraceptives on bone mineral density. Obstet Gynecol. 2008 ; 112 (4). 788-799
26. Endrikat J, Mih E, Dusterberg B, et al. A 3-year double-blind, randomized, controlled study on the influence of two oral contraceptives containing either 20 microg or 30 microg ethinylestradiol in combination with levonorgestrel on bone mineral density. Contraception. 2004 ; 69 (3). 179-187 (Pubitemid 38224215)
27. Reed SD, Scholes D, LaCroix AZ, et al. Longitudinal changes in bone density in relation to oral contraceptive use. Contraception. 2003 ; 68 (3). 177-182 (Pubitemid 38367485)
28. Nappi C, Di Spiezio Sardo A, Acunzo G, et al. Effects of a low-dose and ultra-low-dose combined oral contraceptive use on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study. Contraception. 2003 ; 67 (5). 355-359 (Pubitemid 36556224)
29. Lin K, Barnhart K. The clinical rationale for menses-free contraception. J Womens Health. 2007 ; 16 (8). 1171-1180 (Pubitemid 47587347)
30. Sulak PJ, Carl J, Gopalakrishnan I, et al. Outcomes of extended oral contraceptive regimens with a shortened hormone-free interval to manage breakthrough bleeding. Contraception. 2004 ; 70 (4). 281-287 (Pubitemid 39286762)
31. Reape KZ, DiLiberti CE, Hendy CH, et al. Effects on serum hormone levels of low-dose estrogen in place of placebo during the hormone-free interval of an oral contraceptive. Contraception. 2008 ; 77 (1). 34-39
32. Spona J, Elstein M, Feichtinger W, et al. Shorter pill-free interval in combined oral contraceptives decreases follicular development. Contraception. 1996 ; 54 (2). 71-77 (Pubitemid 26256707)
33. Klipping C, Duijkers I, Trummer D, et al. Suppression of ovarian activity with a drospirenone-containing oral contraceptive in a 24/4 regimen. Contraception. 2008 ; 78 (1). 16-25
34. Clark MK, Sowers MR, Nichols S, et al. Bone mineral density changes over two years in first-time users of depot medroxyprogesterone acetate. Fertil Steril. 2004 ; 82 (6). 1580-1586 (Pubitemid 39611386)
35. Berenson AB, Breitkopf CR, Grady JJ, et al. Effects of hormonal contraception on bone mineral density after 24 months of use. Obstet Gynecol. 2004 ; 103 (5 pt 1). 899-906 (Pubitemid 40458990)
36. Lara-Torre E, Edwards CP, Perlman S, et al. Bone mineral density in adolescent females using depot medroxyprogesterone acetate. J Pediatr Adolesc Gynecol. 2004 ; 17 (1). 17-21 (Pubitemid 38315009)
37. Cundy T, Cornish J, Evans MC, et al. Recovery of bone density in women who stop using medroxyprogesterone acetate. BMJ. 1994 ; 308 (6923). 247-248 (Pubitemid 24089097)
38. Petitti DB, Piaggio G, Mehta S, et al. Steroid hormone contraception and bone mineral density: a cross-sectional study in an international population. The WHO Study of Hormonal Contraception and Bone Health. Obstet Gynecol. 2000 ; 95 (5). 736-744 (Pubitemid 30210062)
39. Scholes D, LaCroix AZ, Ichikawa LE, et al. Injectable hormone contraception and bone density: results from a prospective study. Epidemiology. 2002 ; 13 (5). 581-587
40. Clark MK, Sowers M, Levy B, et al. Bone mineral density loss and recovery during 48 months in first-time users of depot medroxyprogesterone acetate. Fertil Steril. 2006 ; 86 (5). 1466-1474 (Pubitemid 44602060)
41. Kaunitz AM, Miller PD, Rice VM, et al. Bone mineral density in women aged 25-35 years receiving depot medroxyprogesterone acetate: recovery following discontinuation. Contraception. 2006 ; 74 (2). 90-99 (Pubitemid 44096901)
42. Harel Z, Johnson CC, Gold MA, et al. Recovery of bone mineral density in adolescents following the use of depot medroxyprogesterone acetate contraceptive injections. Contraception. 2010 ; 81 (4). 281-291
43. Scholes D, LaCroix AZ, Ichikawa LE, et al. Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone acetate contraception. Arch Pediatr Adolesc Med. 2005 ; 159 (2). 139-144 (Pubitemid 40194179)
44. Cromer BA, Blair JM, Mahan JD, et al. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives. J Pediatr. 1996 ; 129 (5). 671-676 (Pubitemid 27498275)
45. Beksinska ME, Kleinschmidt I, Smit JA, et al. Bone mineral density in young women aged 19-24 after 4-5 years of exclusive and mixed use of hormonal contraception. Contraception. 2009 ; 80 (2). 128-132